PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.15
Bid: 6.80
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.70 (10.294%)
Open: 7.15
High: 7.15
Low: 7.15
Prev. Close: 7.15
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kromek receives Queen’s Award

21 Apr 2020 07:00

RNS Number : 2688K
Kromek Group PLC
21 April 2020
 

21 April 2020

Kromek Group plc

("Kromek" or the "Group")

 

Kromek receives Queen's Award for International Trade

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is delighted to announce that it has received a Queen's Award for Enterprise in recognition of its outstanding contribution to International Trade.

 

The Queen's Awards are the most prestigious awards for UK business, designed to recognise and encourage achievements in the fields of Innovation, International Trade, Sustainable Development and Promoting Opportunity (through social mobility).

 

Kromek has been recognised in the International Trade category for its outstanding growth in overseas sales. In the three years to 30 April 2019, Kromek's non-UK sales grew by 52% to make up 84% of all sales. From its headquarters in Sedgefield, County Durham, Kromek exports its radiation detection technologies and products around the globe to over 40 countries in Europe, North America, Asia and Australasia.

 

Dr Arnab Basu, CEO of Kromek, said: "It is an honour to receive this prestigious award following a period of significant international growth for Kromek. We have secured contracts worth millions of pounds through our deepened relationships with governments and companies worldwide. This has been made possible by the fantastic achievements of our team based on their hard work, innovative skills and commercial focus. It is also recognition of the strength of our market-leading radiation detection products and technologies, which enable us to continue to successfully expand our footprint around the globe."

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

 

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

 

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFBLLLBZLXBBZ
Date   Source Headline
27th Nov 20137:00 amRNSBottle Scanner Orders and New Accreditation
5th Nov 20137:00 amRNSOrders and payments received from global OEMs
31st Oct 20131:28 pmRNSTotal Voting Rights
24th Oct 201311:44 amRNSHolding(s) in Company
21st Oct 20136:08 pmRNSHolding(s) in Company
16th Oct 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.